NCT07500155

Brief Summary

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 29, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

March 24, 2026

Last Update Submit

March 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Device success rate

    Number of patients with device success / Number of recruited patients\* 100%

    during surgery

Secondary Outcomes (1)

  • Ability to assist in the delivery of other interventional devices to the targeted vessel position.

    during surgery

Other Outcomes (1)

  • Incidence of adverse events, serious adverse events and device deficiencies

    within postoperative 24 hrs

Study Arms (1)

single arm

Device: Tarvos Microguidewire

Interventions

This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.

single arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Undertaken a neurovascular surgery procedure including Tarvos Microguidewire

You may qualify if:

  • Undertaken a neurovascular surgery procedure including Tarvos microguidewire
  • Available images of Tarvos Microguidewire in the neurovascular surgery.

You may not qualify if:

  • Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome)
  • Prior vascular dissection or injury to the target vessels
  • Not meeting the data requirements needed for this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xingtai central hospital

Xingtai, China

Location

MeSH Terms

Conditions

Intracranial AneurysmIntracranial Arteriovenous MalformationsArteriovenous FistulaIschemic Stroke

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular DiseasesCentral Nervous System Vascular MalformationsNervous System MalformationsArteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesVascular FistulaFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsStroke

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2026

First Posted

March 30, 2026

Study Start

January 29, 2026

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations